axicabtagene ciloleucel,lisocabtagene maraleucel
bms,gilead
['alycante', 'axi-cel', 'pilot', 'lymsm', 'liso-cel']
alycante 2nd line axi-cel in transplant-ineligible #17icml:
- 62 pts (ineligible mostly due to age)
- cr 66%, mpfs 11.8 mo, no pfs/os diff by age
- high grade crs 8%, icans 15%, 10% nrm
- 12 deaths, 6 due to infections
what does #lymsm think compared to pilot liso-cel? #tcellrx 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈